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Inflammatory adipokines secreted from adipose tissue are major contributors to obesity-
associated inflammation and other metabolic dysfunctions. We and others have recently
documented the contribution of adipose tissue renin-angiotensin system to the pathogene-
sis of obesity, inflammation, and insulin resistance.We hypothesized that adipocyte-derived
angiotensinogen (Agt) plays a critical role in adipogenesis and/or lipogenesis as well as
inflammation.This was tested using 3T3-L1 adipocytes, stably transfected with Agt-shRNA
or scrambled Sc-shRNA as a control. Transfected preadipocytes were differentiated and
used to investigate the role of adipose Agt through microarray and PCR analyses and
adipokine profiling. As expected, Agt gene silencing significantly reduced the expression
of Agt and its hormone product angiotensin II (Ang II), as well as lipid accumulation in 3T3-
L1 adipocytes. Microarray studies identified several genes involved in lipid metabolism
and inflammatory pathways which were down-regulated by Agt gene inactivation, such
as glycerol-3-phosphate dehydrogenase 1 (Gpd1), serum amyloid A 3 (Saa3), nucleotide-
binding oligomerization domain containing 1 (Nod1), and signal transducer and activator of
transcription 1 (Stat1). Mouse adipogenesis PCR arrays revealed lower expression levels
of adipogenic/lipogenic genes such as peroxisome proliferator activated receptor gamma
(PPARγ), sterol regulatory element binding transcription factor 1 (Srebf1), adipogenin (Adig),
and fatty acid binding protein 4 (Fabp4). Further, silencing of Agt gene significantly lowered
expression of pro-inflammatory adipokines including interleukin-6 (IL-6), tumor necrosis
factor-alpha (TNF-α), and monocyte chemotactic protein-1 (MCP-1). In conclusion, this study
directly demonstrates critical effects of Agt in adipocyte metabolism and inflammation and
further support a potential role for adipose Agt in the pathogenesis of obesity-associated
metabolic alterations.
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INTRODUCTION
Obesity is a major risk factor for life-threatening diseases in the
United States and worldwide. Its comorbidities include hyper-
tension, cardiovascular disease, stroke, type-2 diabetes mellitus
(T2DM), and some types of cancer (Ouchi et al., 2011). In obese
individuals, imbalanced secretion of pro- vs. anti-inflammatory
adipokines from abnormally expanded adipose tissue and a
shift in immune cell populations leads to the development of
metabolic complications (Ouchi et al., 2011; Kalupahana and
Moustaid-Moussa, 2012a). In the past decades, multiple stud-
ies (in vitro, in vivo, and clinical) indicated the critical role
of the renin-angiotensin system (RAS) in the pathogenesis of
obesity-associated health disorders. RAS is conventionally known
as a group of hormones and enzymes (renin and angiotensin-
converting enzyme: ACE) which regulate blood pressure and fluid
balance. Angiotensinogen (Agt) is the only known precursor from
which the hypertensive hormone angiotensin (Ang) II and other
bioactive Ang peptides are generated. Ang II mainly functions
through two G-protein coupled receptors, type 1 (AT1) and type
2 (AT2) receptors. In lean individuals, the liver is the major site
for Agt production but RAS components are also expressed in
white and brown adipose tissue, making them relevant to this
work (Karlsson et al., 1998; Engeli et al., 2000; Galvez-Prieto
et al., 2008). Angiotensinogen expression in general has been
shown to be hormonally and nutritionally regulated as well as
differentiation-dependent (Jones et al., 1997a; Siriwardhana et al.,
2012). Specifically Agt is thought to be a late marker for adipocyte
differentiation (Ailhaud et al., 2002), making it relevant to the
current study.
Clinical studies showed that RAS blockade using ACE inhibitors
or AT1 blockers improved the insulin sensitivity and low-
ered the incidence of T2DM in patients with hypertension
or other cardiovascular diseases (Pollare et al., 1989). RAS
blockade also increased the insulin sensitivity and improved
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adiposity in obese and diabetic rodent models (reviewed in
Kalupahana and Moustaid-Moussa, 2012a). The metabolic effects
of RAS were further confirmed in genetic animal models with sys-
temic deletion of certain RAS components (Agt, renin, ACE, AT1a,
or AT2 receptor) (reviewed in Kalupahana and Moustaid-Moussa,
2012a). In vitro studies showed that Ang II stimulated lipogene-
sis and secretion of pro-inflammatory adipokines in adipocytes
(Jones et al., 1997b; Kalupahana et al., 2012).
In obese humans and rodents, adipose tissue is the major
site for Agt production, which significantly increases Agt level
in circulation (Van Harmelen et al., 2000; Boustany et al., 2004;
Engeli et al., 2005). Our lab and others demonstrated that mice
with Agt over-expression in adipose tissue developed obesity with
adipocyte hypertrophy, concurrent with insulin resistance and
increased expression of lipogenic and pro-inflammatory makers
(Massiera et al., 2001a; Kalupahana et al., 2012). Most of these
effects were rescued by deletion of AT2 receptor (Yvan-Charvet
et al., 2009). The genetic mouse model with adipose-specific
Agt gene knock-out exhibited lower systolic blood pressure as
they age, however no change was observed in body weight or
fat mass when fed a low-fat diet (Yiannikouris et al., 2012).
Systemic AGT knock-out mouse models have also been gener-
ated in which body weight, adiposity, leptin, and insulin levels
were significantly lowered on a high-fat diet compared to wild-
type mice. These effects were then reversed when AGT was re-
expressed in adipose tissue (Massiera et al., 2001b; Kim et al.,
2002).
Studies reviewed above link the elevated secretion of Agt from
adipose tissue to obesity-associated local and systemic inflam-
mation as well as insulin resistance, and possibly exacerbated
adiposity. Therefore, we hypothesized that inactivation of Agt
in adipocytes will limit lipid accumulation, and improve the
inflammatory profile.
In the present study, we silenced Agt gene in 3T3-L1 adipocytes
using shRNA, and demonstrated that lower Agt expression leads
to decreased triglyceride accumulation, which is accompanied
by improved expression patterns of adipogenic/lipogenic and
inflammatory genes and proteins in adipocytes.
MATERIALS AND METHODS
CELL CULTURE, shRNA TRANSFECTION, AND PREADIPOCYTE
DIFFERENTIATION
Initially, cell lines were generated as described below using two dif-
ferent shRNA sequences and prepared as both isolated or pooled
clones of stably transfected cells. They were then compared to
cells stably transfected with scrambled sequences. Both shRNA
sequences reduced inflammatory markers and led to significant
inactivation of AGT (>70%). Due to the similarities between the
two sequences, only one was chosen and used for further detailed
experiments as discussed below.
3T3-L1 preadipocytes (American Type Culture Collection;
ATCC, Manassas, VA, USA) were seeded in two 6-well cell cul-
ture plates. Each well had 2 ml Dulbecco’s modified eagle medium
(DMEM) supplemented with 10% fetal bovine serum (FBS).
Cells were incubated at 37˚C in a humidified CO2 incubator.
The vector-based shRNA targeting Agt gene (Agt-shRNA, GGATC
CCGTTTCTACCTTGGATCCTAGATTGATATCCGTCTAAGGA
TCCAAGGTAGAAATTTTTTCCAAAAGCTT) was ordered from
GenScript (Piscataway, NJ, USA). A scrambled sequence
(Sc-shRNA,GGATCCCGTCGCTTACCGATTCAGAATGGTTGAT
ATCCGCCATTCTGAATCGGTAAGCGACGAAGCTTAAGTTTA
AACCGCTGATCAGCCTCGACTGTGCCTTCTAGT) with no
homology to any mouse or rat mRNA sequence in NCBI data-
base was used as experimental control. These vectors carried a
neomycin resistance gene.
Cells were stably transfected at ∼50–60% confluence. The
transfection was performed using Lipofectamine™ 2000 Transfec-
tion Reagent (Life Technologies, Grand Island, NY, USA) method.
3T3-L1 preadipocytes transfected by Agt-shRNA or Sc-shRNA
were maintained in regular growth medium (DMEM contain-
ing 10% FBS, 1% penicillin/streptomycin) till 90% confluence.
To differentiate the preadipocytes to mature adipocytes, cells were
maintained in regular growth medium supplemented by isobutyl-
methylxanthine (0.5 mM), dexamethasone (0.25µM), and insulin
(1µg/ml) for 3 days, followed by regular growth media for another
3 days. Several cell lines were generated from these stable trans-
fections and referred to as Agt-ShRNA1, 2, etc. Overall, Agt was
silenced by more than 70% in these cell lines.
AGT AND ANG II MEASUREMENT
Total protein was extracted using tissue lysis buffer (Life Tech-
nologies, Grand Island, NY, USA) containing protease inhibitors
(Roche, USA). The concentration of extracted protein samples
was determined by Bradford assay (Thermo Scientific/Pierce,
Rockford, IL, USA).
The expression level of Agt protein was measured by west-
ern blotting. Each sample of 25µg total protein from 3T3-L1
adipocytes transfected by Agt-shRNA or Sc-shRNA (3 vs. 3) was
first separated by electrophoresis using 12% Mini-PROTEAN TGX
Precast Gel (Bio-Rad, Hercules, CA, USA), and then transferred to
a PVDF membrane. After overnight blocking (3% bovine serum
albumin in tris-buffered-saline supplemented by 0.1% Tween 20),
the membrane was incubated with polyclonal antibodies targeting
Agt protein (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
After a wash (tris-buffered-saline with 0.1% Tween 20), the mem-
brane was incubated with the secondary antibodies containing
horseradish peroxidase. The expression of Agt was detected with
the ECL Plus substrate (Thermo Scientific/Pierce, Rockford, IL,
USA), and quantified using the NIH ImageJ software. The expres-
sion level of Agt protein was normalized by the expression of
glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
The intracellular level of Ang II was measured by Angiotensin II
EIA Kit (Cayman Chemical, Ann Arbor, MI, USA). To perform the
assay, 10µL of each total protein sample from 3T3-L1 adipocytes
transfected by Agt-shRNA or Sc-shRNA (n= 5 each) was used.
The analyte value was normalized by total protein concentration.
LIPID ACCUMULATION ASSAY
3T3-L1 adipocytes transfected by Agt-shRNA or Sc-shRNA (n= 5
each) were washed with PBS, and then harvested in PBS sup-
plemented by 10% IGEPAL CA-630 (detergent, Sigma-Aldrich,
St. Louis, MO, USA). Cells were then transferred to a 2 ml auto-
claved centrifuge tube and homogenized for 15 s. The triglyceride
content in cell lysate was measured using Serum Triglyceride
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Determination Kit (Sigma-Aldrich, St. Louis, MO, USA). The
analyte value was normalized by total protein concentration.
PRO-INFLAMMATORY ADIPOKINE PROFILING
The intracellular level of pro-inflammatory adipokines (IL-1,
TNF-α, MCP-1, PAI-1, and resistin) was measured by the Mouse
Serum Adipokine Milliplex Kit (Millipore, Billerica, MA, USA). To
perform the assay, total protein sample from 3T3-L1 adipocytes
transfected by Agt-shRNA or Sc-shRNA (n= 5 each) was used.
The analyte value was normalized by protein concentration.
MICROARRAY
Total RNA was extracted from 3T3-L1 adipocytes transfected
with Agt-shRNA or Sc-shRNA using RNeasy lipid tissue kit (Qia-
gen, Valencia, CA, USA). Four sets of RNA samples each were
used for microarray analyses. The concentration of these RNA
samples was measured using NanoDrop 2000 (Thermo Scien-
tific, USA), and the quality was determined by the Experion
RNA StdSens Chips (Bio-Rad, Hercules, CA, USA). Samples
were sent to the McGill University’s Génome Québec Innova-
tion Center (Montréal, Canada) and Illumina MouseRef-8 V2.0
Expression Beadchips (Illumina, San Diego, CA, USA) were
used to measure 25,697 RefSeq transcripts, over 19,100 genes.
David Bioinformatics Database 6.71 (NIAID/NIH) was used for
the ontology and pathway analysis on genes with differential
expression.
QUANTITATIVE REAL-TIME PCR
The expression pattern of selected genes with differential expres-
sion in the microarray analyses was verified by quantitative Real-
Time PCR (qRT-PCR). Total RNA samples extracted from 3T3-L1
adipocytes transfected with Agt-shRNA or Sc-shRNA (n= 4 each)
were used for cDNA synthesis using the High Capacity cDNA RT
kit (Applied Biosystems, Carlsbad, CA, USA). All primers used
in this study were purchased from Qiagen (QuantiTect Primer
Assay). The real-time PCR was performed on Applied Biosys-
tems 7900HT Fast Real-Time PCR System using the Fast SYBR
Master Mix (Applied Biosystems, Carlsbad, CA, USA). The expres-
sion level of housekeeping gene β-actin (Actb) was measured
as reference to normalize the expression level of genes under
investigation.
PCR ARRAY
The expression of genes associated with adipocyte metabolism
was profiled by Mouse Adipogenesis RT2 Profiler™ PCR Array
(SABiosciences, Qiagen, Valencia, CA, USA), which targets 84 core
genes in mouse adipogenesis pathway. The array kit also con-
tains five housekeeping genes, which include Actb. Total RNA
samples extracted from 3T3-L1 adipocytes transfected with Agt-
shRNA or Sc-shRNA (n= 4 each) were used for the synthesis of
cDNA using RT2 First Strand Kit (SABiosciences, Qiagen, Valen-
cia, CA, USA). RT-PCR was performed on the same equipment as
described previously using the RT2 SYBR Green qPCR Mastermix
(SABiosciences, Qiagen, Valencia, CA, USA). David Bioinformat-
ics Database 6.7 (see text footnote 1, NIAID/NIH) was used for
the gene ontology analysis.
1http://david.abcc.ncifcrf.gov/tools.jsp
STATISTICAL ANALYSES
In this study, microarray data were analyzed by R software
(version 2.9.0) using “lumi” package in bioconductor2. Signifi-
cant differential expression in 3T3-L1 adipocytes with Agt gene
silencing compared to the adipocytes transfected by Sc-shRNA
was defined as an FDR adjusted P value< 0.05.
Data from qRT-PCR and PCR array studies were analyzed by
the web-based software3 (SABiosciences) using 2−∆∆CT method.
The expression level for genes of interest was normalized by the
expression of Actb housekeeping gene.
All other analyses were performed using SAS software (version
9.2, Cary, NC, USA). Results were reported as means± SE. One
way ANOVA followed by Tukey post hoc test was used to compare
the group means at P < 0.05.
RESULTS
ANGIOTENSINOGEN GENE SILENCING REDUCED AGT PROTEIN
EXPRESSION AND INTRACELLULAR LEVEL OF ANG II IN 3T3-L1
ADIPOCYTES
Successful transfection of Agt-shRNA into 3T3-L1 preadipocytes
was demonstrated by the significantly lower expression of Agt pro-
tein in 3T3-L1 adipocytes expressing Agt-shRNA vs. Sc-shRNA
(Figures 1A,B; P < 0.005). As Agt is the precursor for the hyper-
tensive hormone Ang II, we further measured the intracellular
level of Ang II, which was also decreased in 3T3-L1 adipocytes
expressing Agt-shRNA vs. Sc-shRNA (Figure 1C; P < 0.0001).
AGT GENE SILENCING DECREASED LIPID ACCUMULATION AND
INTRACELLULAR LEVEL OF PRO-INFLAMMATORY ADIPOKINES IN
3T3-L1 ADIPOCYTES
Previous studies have reported that Ang II increases the triglyc-
eride content in 3T3-L1 adipocytes (Jones et al., 1997b). Here,
we determined the role of RAS in mediating lipogenesis by
directly knocking down the expression of Ang II precursor –
Agt gene. Agt gene silencing significantly reduced the triglyc-
eride content in 3T3-L1 adipocytes expressing Agt-shRNA vs.
Sc-shRNA (Figure 2A; P < 0.005). Studies have also shown that
Ang II stimulates the secretion of pro-inflammatory adipokines
from both human and 3T3-L1 adipocytes. In this study, we
measured the intracellular level of major pro-inflammatory
adipokines (IL-6, TNF-α, MCP-1, resistin, and PAI-1). The
results showed lower IL-6, TNF-α, and MCP-1 protein levels in
3T3-L1 adipocytes transfected with Agt-shRNA vs. Sc-shRNA
(Figure 2B). This indicated Agt as an important mediator in
adipose inflammation.
AGT GENE SILENCING INDUCED CHANGES IN THE EXPRESSION OF
GENES INVOLVED IN LIPID METABOLISM AND IMMUNE RESPONSE
PATHWAYS
To dissect the underlying mechanism which mediates the meta-
bolic effects of Agt in adipocytes, a microarray study was per-
formed on 3T3-L1 adipocytes transfected by Agt-shRNA or Sc-
shRNA. After filtering out 16,561 transcripts with insignificant
expression, we conducted statistical analysis on the remaining
2http://www.bioconductor.org/
3http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php
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FIGURE 1 | Agt gene silencing induces lower Agt protein expression
and intracellular level of Ang II. 3T3-L1 preadipocytes were transfected
by shRNA targeting Agt gene (Agt-shRNA) or scrambled shRNA
(Sc-shRNA), and then differentiated to mature adipocytes. (A,B) Agt protein
expression, and (C) intracellular level of Ang II are shown. Data are
presented as mean±SE [n=3 for each group in (A), n=5 for each group in
(C)]. The expression of Agt is normalized by the expression of GAPDH. The
intracellular level of Ang II is normalized by total protein concentration.
*P <0.005 vs. adipocytes transfected by Sc-shRNA.
9,136 transcripts. Compared to cells transfected with Sc-shRNA,
the expression of 89 genes was significantly down-regulated and
the expression of 23 genes was up-regulated in 3T3-L1 adipocytes
with Agt gene silencing (Figure 3A). A heat map was plot-
ted by cluster analysis on genes with differential expression in
3T3-L1 adipocytes transfected with Agt-shRNA vs. Sc-shRNA. The
expression patterns of these genes were highly consistent within
each adipocyte cell line, as shown in Figure 3B.
Gene ontology and pathway analysis showed that the expression
of several critical genes involved in lipid metabolism and inflam-
matory response was down-regulated in 3T3-L1 adipocytes with
Agt gene silencing; selected genes are listed in Tables 1 and 2. Other
FIGURE 2 | Agt gene silencing leads to lower triglyceride accumulation
and intracellular level of pro-inflammatory adipokines in 3T3-L1
adipocytes. 3T3-L1 preadipocytes were transfected by shRNA targeting
Agt gene (Agt-shRNA) or scrambled shRNA (Sc-shRNA), and then
differentiated to mature adipocytes. Triglyceride content (A) and adipokine
concentration (B) is normalized by total protein concentration. Data are
presented as mean±SE (n=5 for each group). *P <0.05 vs. adipocytes
transfected by Sc-shRNA.
genes with decreased expression in 3T3-L1 adipocytes with Agt
gene silencing were genes involved in energy metabolism, immune
response, oxidative stress, cell differentiation, and apoptosis. Genes
with up-regulated expression in 3T3-L1 adipocytes with Agt gene
silencing were ones involved in DNA replication, transcription,
translation, repair, chromosomal structure, intracellular protein
trafficking, protein phosphorylation, and proteolysis. These genes
are listed in Table A1 in Appendix.
To determine whether the profile of global gene expression from
the microarray study were consistent with the relative amounts of
mRNA present in parallel samples, qRT-PCR was performed on
selected genes (Cxcl12, Stat1, Saa3, Nod1, Gpd1, and Acad10).
Consistent with microarray results, the expression level of all
these genes were down-regulated in 3T3-L1 adipocytes with Agt
gene silencing compared to those transfected with Sc-shRNA
(Figure 4).
Since knock-down of Agt gene decreased lipid accumulation
and the expression of genes associated with lipid metabolism in
3T3-L1 adipocytes, we further profiled the expression pattern of
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FIGURE 3 | Agt gene silencing induces changes in global gene
expression patterns in 3T3-L1 adipocytes. 3T3-L1 preadipocytes were
transfected by shRNA targeting Agt gene (Agt-shRNA) or scrambled shRNA
(Sc-shRNA), and then differentiated into mature adipocytes. Changes in
global gene expression patterns were profiled by microarray study. Genes
with significant differential expression in 3T3-L1 adipocytes transfected
with Agt-shRNA vs. Sc-shRNA were determined by the false discovery rate
(FDR) adjusted P value<0.05 (A). Heat map with genes of differential
expression is shown in (B). The rows represent the patterns of gene
expression, and columns represent samples. Red region corresponds to
genes with down-regulated expression, and yellow region corresponds to
genes with up-regulated expression, in 3T3-L1 adipocytes transfected with
Agt-shRNA vs. Sc-shRNA (n= 4 for each cell line).
genes in the adipogenesis pathways using a PCR array. The results
confirmed the lower expression of Agt gene at transcription level,
and showed decreased expression of several adipogenic genes,
including PPAR-γ, Cebpb, Srebf1 and Adig, and lipid metabolic
markers Ppargc1b and Fabp4 in 3T3-L1 adipocytes with Agt gene
silencing. Conversely, the expression of genes with anti-adipogenic
effects, Gata3, and Vdr, were up-regulated. The expression pattern
of these genes is shown in Figure 5, and the functions of these
genes are described in Table 3.
DISCUSSION
Recent studies indicated the potential role of adipose tissue-
derived Agt in the pathogenesis of metabolic disorders. However,
the underlying mechanisms mediating these effects are not well
clarified. In the present study, we successfully established Agt gene
silencing in 3T3-L1 adipocytes using shRNA, which effectively
decreased the intracellular level of Agt and Ang II,and enabled us to
directly investigate the metabolic effects of adipose Agt. Using this
in vitro model, we confirmed the direct contribution of adipocyte-
derived Agt and Ang II to preadipocyte differentiation, lipogenesis,
and adipocyte inflammation, as evidenced by decreased triglyc-
eride accumulation, and pro-inflammatory adipokine production,
as well as down-regulated expression of several adipogenic and
inflammatory genes.
RAS AND ADIPOSITY
The present study confirmed the effects of Agt/Ang II in promot-
ing lipogenesis. Our lab previously reported that Ang II increases
lipogenesis in 3T3-L1 and human adipocytes (Jones et al., 1997b).
In line with these findings, we demonstrated in this study that
inactivation of Agt gene significantly reduced the lipid accumu-
lation during 3T3-L1 preadipocyte differentiation. This is also
in agreement with a recent study where shRNA-mediated Agt
gene silencing inhibited triglyceride storage during human vis-
ceral preadipocyte differentiation (Ye et al., 2010). Indeed, in these
studies, the expression of Gpd1 gene which encodes glycerol-
3-phosphate dehydrogenase 1 was increased in Ang II treated
3T3-L1 adipocytes (Jones et al., 1997b) but decreased by knock-
down of the Agt gene in human preadipocytes. Consistently, we
identified here that the expression of Gpd1 gene was decreased
in 3T3-L1 adipocytes with Agt gene silencing. In this study, no
change was detected in the gene expression of acetyl-coenzyme
A carboxylase or fatty acid synthase, the major enzymes mediat-
ing de novo lipogenesis. Therefore, the lower lipid accumulation
in 3T3-L1 adipocytes with Agt gene silencing is potentially due
to the decreased synthesis of glycerol by Gpd1 in the process
of lipogenesis. It is also possible that Agt gene silencing down-
regulates the activity of lipogenic enzymes, and inhibits the de
novo lipogenesis in 3T3-L1 adipocytes. Ang II was previously
shown to inhibit preadipocyte differentiation, which was poten-
tially mediated by the AT1 receptor. Similarly, certain AT1 blockers
enhanced preadipocyte differentiation in both 3T3-L1 and human
preadipocytes, and mice with systemic knock-out of AT1a recep-
tor showed adipocyte hypotrophy (Janke et al., 2002, 2006; Schupp
et al., 2004). However, in this study, we identified that Agt gene
silencing inhibited 3T3-L1 preadipocyte differentiation through
down-regulating the expression of core adipogenic genes (C/EBP-
β and PPAR-γ) and other adipogenic markers (Srebf1 and Adig)
which mediate the initiation of adipogenesis. Agt gene silencing
also decreased the expression of several lipid metabolic genes
(Fabp4 and Ppargc1b). Genes with anti-adipogenic effects (Gata3
and Vdr) were also up-regulated in Agt-shRNA transfected cells.
These indicated Agt as a critical factor with stimulatory effects
on preadipocyte differentiation. We propose that the effect of
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Table 1 | Lipid metabolic genes differentially expressed in 3T3-L1 adipocytes transfected by Agt-shRNA vs. Sc-shRNA.
Gene
symbol
Gene name Fold
change
P value
(FDR adjusted)
Function
Gpd1 Glycerol-3-phosphate dehydrogenase 1 0.34 0.003919 A lipogenic marker, catalyzes the reversible conversion of
dihydroxyacetone phosphate to sn-glycerol-3-phosphate
Ces3 Carboxylesterase 3 0.24 0.000087 Adipocyte lipase, mediates lipolysis
Retsat Retinol saturase 0.63 0.025349 Saturates13-14 double bond of all-trans-retinol to produce
all-trans-13, 14-dihydroretinol
Acad10 Acyl-Coenzyme A dehydrogenase family,
member 10
0.78 0.050300 Catalyzes the initial step of mitochondria fatty acid
β-oxidation
Apoc1 Apolipoprotein C-I 0.48 0.001845 Modulates the interaction of APOE with beta-migrating
VLDL, inhibits the binding of beta-VLDL to LDL
receptor-related protein
Hsd3b7 Hydroxy-delta-5-steroid dehydrogenase, 3
beta-, and steroid delta-isomerase 7
0.80 0.048719 Plays a crucial role in the biosynthesis of hormonal steroids
Suclg1 Succinate-CoA ligase, GDP-forming, alpha
subunit, mitochondrial
0.72 0.037140 An enzyme in tricarboxylic acid cycle, catalyzes ATP- or GTP-
dependent ligation of succinate and CoA to form
succinyl-CoA in mitochondrial matrix
FDR, false discovery rate.
Table 2 | Inflammatory genes differentially expressed in 3T3-L1 adipocytes transfected by Agt-shRNA vs. Sc-shRNA.
Gene
symbol
Gene name Fold
change
P value
(FDR adjusted)
Function
Saa3 Serum amyloid A 3 0.57 0.025314 Major acute phase protein, in response to cytokine
stimulation
Nod1 Nucleotide-binding oligomerization
domain containing 1
0.75 0.029593 Induces NF-κ B activation via RIPK2 and IKK-gamma,
enhances caspase-9-mediated apoptosis
Cxcl12 Chemokine (C-X-C motif) ligand 12 0.38 0.046402 Chemoattractant for T-lymphocytes and monocytes
Ptx3 Pentraxin related gene 0.71 0.033282 Activates classical complement pathway, facilitates
pathogen recognition by immune cells
Stat1 Signal transducer and activator of
transcription 1
0.66 0.029154 A member of signal transducers and activators of
transcription (STATs) family, mediates cytokine signaling
Irf9 Interferon regulatory factor 9 0.64 0.029593 Plays a critical role in stimulating IFN-alpha responsive genes
FDR, false discovery rate.
Ang II on adipogenesis is receptor specific, and dose dependent.
Possibly, low to regular levels of Ang II stimulate adipogenesis
through the AT2 receptor, which overcomes the anti-adipogenic
effect mediated by the AT1 receptor. However, high levels of
Ang II could activate the AT1 receptor and inhibit preadipocyte
differentiation.
Our microarray study detected multiple genes associated with
adipocyte metabolism which were down-regulated by Agt gene
silencing. Retsat (encodes retinol saturase) is induced during
3T3-L1 preadipocyte differentiation and promotes adipogenesis
through increased PPAR-γ transcriptional activity (Schupp et al.,
2009).
Ang II is an active mediator of lipolysis in a time-dependent
manner. Short term treatment of Ang II inhibits lipolysis in
human adipose tissue and adipocytes through the AT1 receptor
(Boschmann et al., 2001; Goossens et al., 2004, 2007). However,
long term infusion of Ang II markedly increased lipolysis in rats
(Cabassi et al., 2005). One explanation for this could be the Ces3
gene which encodes for carboxylesterase 3 (triacylglycerol hydro-
lase, TGH) – an adipocyte lipase – whose expression was decreased
in 3T3-L1 adipocytes with Agt gene silencing.
Lastly, our microarray and RT-PCR data indicated that Agt gene
widely affects the whole process of lipid metabolism in adipocytes.
This was seen in the expression of other genes down-regulated by
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FIGURE 4 | Agt gene silencing induces down-regulated expression of
Cxcl12, Stat1, Saa3, Nod1, Gpd1, and Acad10 genes in 3T3-L1
adipocytes. 3T3-L1 preadipocytes were transfected by shRNA targeting
Agt gene (Agt-shRNA) or scrambled shRNA (Sc-shRNA), and then
differentiated to mature adipocytes. Data are presented as mean±SE, and
calculated according to the 2−∆∆CT method (n=4 for each group).
*P <0.0001 vs. adipocytes transfected by Sc-shRNA.
FIGURE 5 | Agt gene silencing induces changes in the expression of
genes associated with adipogenesis pathway in 3T3-L1 adipocytes.
3T3-L1 preadipocytes were transfected by shRNA targeting Agt gene
(Agt-shRNA) or scrambled shRNA (Sc-shRNA), and then differentiated to
mature adipocytes. Data are presented as mean±SE, and calculated
according to the 2−∆∆CT method (n=4 for each group). *P < 0.05 vs.
adipocytes transfected by Sc-shRNA.
Agt gene silencing, such as Acad10, Apoc1, Suclg1, and Hsd3b7,
which are involved in lipid transport, β oxidation, TCA cycle, and
biosynthesis of steroid hormones from lipids.
RAS AND INFLAMMATION
While it has been established that obesity leads to chronic low-
grade inflammation in adipose tissue (Kalupahana and Moustaid-
Moussa, 2012a), the exact trigger for this process is unknown.
Adipose tissue-secreted Agt has been shown to induce obesity-
associated inflammation, a major factor for the pathogenesis
of metabolic disorders, and therefore is a potential target for
obesity research as described below (Kalupahana and Moustaid-
Moussa,2012b). In obesity, adipose tissue-derived Agt significantly
increases the level of Agt in circulation (Van Harmelen et al.,
2000; Boustany et al., 2004; Engeli et al., 2005). Moreover, our
lab and collaborators further showed that adipose-specific Agt
over-expression induced local and systemic inflammation, as well
as insulin resistance in mice (Kalupahana et al., 2012).
Previous studies reported that Ang II stimulated the secre-
tion of several pro-inflammatory adipokines from both 3T3-L1
and human adipocytes (Skurk et al., 2001, 2004). Consistent with
those studies, we demonstrated here that Agt gene silencing in
3T3-L1 adipocytes significantly reduced the intracellular level
of pro-inflammatory adipokines, including MCP-1, IL-6, and
TNFα.
In the current research, the microarray study identified that
Agt gene silencing decreased the expression of several genes
involved in adipose inflammation including Saa3, Nod1, Stat1,
and Cxcl12. Saa3, which encodes for the acute phase protein –
serum amyloid A3, was recently identified as a critical pro-
inflammatory adipokine involved in obesity-associated metabolic
disorders (Yang et al., 2006). A previous study showed that block-
ing the AT1 receptor suppressed the mRNA expression of Saa3,
together with TNF-a, PAI-1, and MCP-1 in mice adipose tissue
(Kurata et al., 2006). The present study further confirmed that
Saa3 as a critical factor involved in Ang II-induced inflammatory
disorders, as silencing of Agt in cultured adipocytes reduced Saa3
expression.
Nod1 gene encodes an intracellular pattern recognition recep-
tor mediating immune response. The activation of this receptor
induces peripheral and hepatic insulin resistance, which is pre-
vented when this gene in inactivated (Schertzer et al., 2011).
Activation of NOD1 also increases pro-inflammatory adipokine
secretion and impairs the insulin-stimulated glucose uptake in
3T3-L1 and primary murine adipocytes (Schertzer et al., 2011;
Zhao et al., 2011). Since Agt silencing reduced NOD1, this suggests
that Nod1 is a potential mediator for Ang II-induced adipocyte
inflammation.
Stat1 is a member in the Stats family – the major compo-
nent of Jak-Stat pathway which plays a critical role in mediat-
ing cytokine signaling. Jak-Stat pathway mediates the action of
hormones which impact adipocyte development and functions
(Richard and Stephens, 2011). Stats mediate the activation of mul-
tiple inflammatory pathways, such as NF-κB and c-Jun (O’Shea
et al., 2002). The lowered expression of the Stat1 gene, in part, indi-
cates that Agt gene silencing down-regulates the cytokine signaling
in 3T3-L1 adipocytes. Interferon regulatory factors (Irfs), which
mainly respond to interferon in the JAK-STAT signaling pathway
(O’Shea et al., 2002; Eguchi et al., 2008), could be one avenue of this
down-regulation. Previous studies reported that IFN-α/β induced
a complex formation of STAT1, STAT2, and IRF9, one of the Irfs
which are expressed in adipocytes (Eguchi et al., 2008). Together
these indicate that Agt gene silencing induced a consistent change
pattern in cytokine signaling pathway (O’Shea et al., 2002; Eguchi
et al., 2008).
Several other chemokines were altered by Agt inactivation.
These include Cxcl12 and Ptx3. Cxcl12 is mainly expressed in stro-
mal cells, but is also detected in 3T3-L1 adipocytes (Choi et al.,
2010). This indicates the potential role of this gene in inducing
the immune cells infiltration in adipose tissue. The expression
of Ptx3 gene is up-regulated during preadipocyte differentia-
tion, and although almost non-detectable in mature adipocytes,
it can be re-activated in 3T3-F442A adipocytes upon TNF-α
stimulation (Abderrahim-Ferkoune et al., 2003). The decreased
expression of Ptx3 gene in 3T3-L1 adipocytes with Agt gene
silencing is potentially mediated by decreased adipogenesis and
TNF-α (Abderrahim-Ferkoune et al., 2003).
www.frontiersin.org March 2013 | Volume 4 | Article 10 | 7
Carroll et al. Angiotensiongen gene silencing in adipocytes
Table 3 | Genes with differential expression associated with adipogenesis pathway in 3T3-L1 adipocytes transfected by Agt-shRNA vs.
Sc-shRNA.
Gene
symbol
Gene name Fold
change
P value Function
Pparg Peroxisome proliferator activated
receptor gamma
0.4808 0.030656 Key regulator of glucose homeostasis and preadipocyte
differentiation
Cebpb CCAAT/enhancer binding protein
(C/EBP), beta
0.5718 0.038756 Plays a catalytic role in preadipocyte differentiation
Srebf1 Sterol regulatory element binding
transcription factor 1
0.5070 0.008977 Regulates glucose metabolism, fatty acid, and lipid (mainly
cholesterol) synthesis
Adig Adipogenin 0.5619 0.005956 An adipocyte-specific protein, promotes adipocyte
differentiation
Ppargc1b Peroxisome proliferative activated
receptor, gamma, coactivator 1 beta
0.2017 0.045250 Stimulates the activation of transcription factors. Involved in
fat oxidation, and non-oxidative glucose metabolism
Fabp4 Fatty acid binding protein 4 0.4094 0.002358 Adipocytes specific lipid transport protein
Gata3 GATA binding protein 3 2.6291 0.003210 Suppresses preadipocytes differentiation through PPAR-γ
Vdr Vitamin D receptor 1.8460 0.003185 Suppresses preadipocytes differentiation through C/EBP
and PPAR-γ
FIGURE 6 | Proposed mechanisms for Ang II-induced metabolic
disorders. Adipocyte-derived Agt is converted to Ang II which affects
adipocytes in autocrine or paracrine manner through angiotensin receptors.
Ang II activates inflammatory pathways, and increases the secretion of
pro-inflammatory adipokines, which inhibit insulin signaling and induce insulin
resistance. Ang II also stimulates lipogenesis in adipocytes, leading to
adipocyte hypertrophy which potentially activates inflammatory pathways and
exacerbates these inflammatory conditions.
Elevated level of RAS components was detected in adipose tis-
sue and circulation in obese human subjects and animals (Van
Harmelen et al., 2000; Boustany et al., 2004; Engeli et al., 2005).
Animal models with systemic deletion of RAS components (Agt,
renin,ACE,AT1a, and AT2) were protected from diet-induced obe-
sity and metabolic disorders (Massiera et al., 2001b). Transgenic
mice with Agt over-expression in adipose tissue exhibit adiposity,
adipocyte hypertrophy, adipose and systemic inflammation, and
insulin resistance (Kalupahana et al., 2012). However, mice with
Agt gene specifically knock-out from adipose tissue had no change
in fat mass or body weight (Yiannikouris et al., 2012). These indi-
cate that elevated secretion of Agt from adipose tissue may in part
mediate obesity-associated metabolic disorders.
In summary, this study showed that gene silencing induced
lower adipocyte-derived-Agt, which led to decreased lipid
accumulation and pro-inflammatory adipokines production, as
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well as down-regulated expression of adipogenic and lipid meta-
bolic markers and genes in inflammatory pathways. The underly-
ing mechanism for the metabolic effect of Ang II is summarized
in Figure 6.
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APPENDIX
Table A1 | Genes differentially expressed in 3T3-L1 adipocytes transfected with Agt-shRNA vs. Sc-shRNA.
Gene symbol Gene name Fold change P value
(FDR adjusted)
ENERGY METABOLIC PROCESS
Por P450 (cytochrome) oxidoreductase 0.613868 0.004184
Aldh2 Aldehyde dehydrogenase 2, mitochondrial 0.656561 0.022585
Cdo1 Cysteine dioxygenase 1, cytosolic 1.806253 0.041216
Cyb561 Cytochrome b-561 0.661127 0.029593
Idh3g Isocitrate dehydrogenase 3 (NAD+), gamma 0.65022 0.021874
Hibadh 3-hydroxyisobutyrate dehydrogenase 0.729005 0.033282
Phgdh Phosphoglycerate dehydrogenase 0.688725 0.035963
gm2a GM2 ganglioside activator protein 0.511569 0.029154
AU018778 Expressed sequence AU018778 (type-B carboxylesterase/lipase) 0.439825 0.000356
Atp6ap1 ATPase, H+ transporting, lysosomal accessory protein 1 0.666187 0.031342
Acaa1b Acetyl-Coenzyme A acyltransferase 1B 0.627201 0.031219
Adhfe1 Alcohol dehydrogenase, iron containing, 1 0.669428 0.029465
Gpt Glutamic pyruvic transaminase, soluble 0.482968 0.014529
Gsta4 Glutathione S-transferase, alpha 4 0.541488 0.025158
Gstm2 Glutathione S-transferase, mu 2 0.71847 0.008982
Cox8b Cytochrome c oxidase, subunit VIIIb 0.32511 0.003044
Cox6c Cytochrome c oxidase subunit Vic 2.011121 0.022585
IMMUNE RESPONSETO EXTRACELLULAR STIMULUS
C4b Complement component 4B 0.6 0.041924
B2m Beta-2 microglobulin 0.717475 0.0322
Tap2 Transporter 2, ATP-binding cassette, sub-family B 0.634635 0.043325
Igtp Interferon gamma induced GTPase 0.533293 0.031471
Ifit3 Interferon-induced protein with tetratricopeptide repeats 3 0.198333 0.031219
Cd99l2 CD99 antigen-like 2 0.647073 0.043325
RESPONSETO HORMONE STIMULUS
Serpina3c Serine peptidase inhibitor, clade A, member 3C 0.712025 0.045332
Serpina3g Serine peptidase inhibitor, clade A, member 3G 0.388773 0.001845
Serpina3h Serine peptidase inhibitor, clade A, member 3H 0.494143 0.013389
Serpina3n Serine peptidase inhibitor, clade A, member 3N 0.505226 0.000321
SMALL GTPASE MEDIATED SIGNALTRANSDUCTION
Rasl11a RAS-like, family 11, member A 0.674084 0.019568
Rasl11b RAS-like, family 11, member B 0.573156 0.001066
Rab3d RAB3D, member RAS oncogene family 0.72951 0.034662
Rhob Ras homolog gene family, member B 1.666706 0.040915
Rhoj Ras homolog gene family, member J 0.691116 0.031471
OTHER GENES OF INTEREST
Aatk Apoptosis-associated tyrosine kinase 0.564091 0.022585
Renbp Renin binding protein 0.643495 0.031471
Aqp7 Aquaporin 7 0.565265 0.003405
Bmp1 Bone morphogenetic protein 1 0.634635 0.034934
Bst2 Bone marrow stromal cell antigen 2 0.334250 0.013389
Cenpa Centromere protein A 1.455989 0.022585
Dbp D site of albumin promoter binding protein 0.645728 0.043573
Enpp5 Ectonucleotide pyrophosphatase/phosphodiesterase 5 0.732550 0.0322
Fhod1 Formin homology 2 domain containing 1 1.371733 0.041924
Fkbp5 FK506 binding protein 5 1.215879 0.036674
Gas6 Growth arrest-specific 6 0.468785 0.037595
(Continued)
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Table A1 | Continued
Gene symbol Gene name Fold change P value
(FDR adjusted)
Gatad1 GATA zinc finger domain containing 1 1.747145 0.003405
Gtf3c5 General transcription factor IIIC, polypeptide 5 1.264003 0.0322
Hist1h2ah Histone cluster 1, H2ah 1.634670 0.040326
Hp Haptoglobin 0.657015 0.030981
Hspb8 Heat shock 22kDa protein 8 0.668963 0.022585
Ifi27 Interferon, alpha-inducible protein 27 0.309497 0.03069
Ift20 Intraflagellar transport 20 homolog 1.485552 0.031471
Itih4 Inter-alpha (globulin) inhibitor H4 0.243332 0.000025
Klc1 Kinesin light chain 1 1.278985 0.035963
Matn4 Matrilin 4 0.641712 0.031471
Mettl7B Methyltransferase like 7B 0.704660 0.048333
Mid1ip1 MID1 interacting protein 1 0.720464 0.045125
Mpp1 Membrane protein, palmitoylated 1, 55kDa 0.744322 0.041924
Nasp Nuclear autoantigenic sperm protein (histone-binding) 1.336074 0.048719
Nup107 Nucleoporin 107kDa 0.657927 0.029465
Pde1b Phosphodiesterase 1B, calmodulin-dependent 1.522033 0.013389
Pde4dip Phosphodiesterase 4D interacting protein 0.654289 0.038052
Prelp Proline/arginine-rich end leucine-rich repeat protein 0.677362 0.034934
Psmc5 Proteasome (prosome, macropain) 26S subunit, ATPase, 5 1.387030 0.029465
Pxmp2 Peroxisomal membrane protein 2, 22 kDa 0.660669 0.033282
Rdbp RD RNA binding protein 1.263127 0.045125
Rps24 Ribosomal protein S24 1.791291 0.022585
S100A13 S100 calcium binding protein A13 1.580082 0.022585
Aimp1 AminoacyltRNAsynthetase complex-interacting multifunctional protein 1 1.354724 0.025849
Slc5a6 Solute carrier family 5 (sodium-dependent vitamin transporter), member 6 0.756283 0.048936
Thrsp Thyroid hormone responsive 0.264621 0.001714
Tk1 Thymidine kinase 1, soluble 1.629015 0.022786
Tmed4 Transmembrane emp24 protein transport domain containing 4 0.777007 0.045125
Tmem43 Transmembrane protein 43 0.637722 0.022585
Tmem45B Transmembrane protein 45B 0.718470 0.041924
Tpm2 Tropomyosin 2 (beta) 1.418140 0.041924
Trafd1 Traf-type zinc finger domain containing 1 0.692074 0.004184
Uba7 Ubiquitin-like modifier activating enzyme 7 0.668037 0.048719
Uck2 Uridine-cytidine kinase 2 1.286097 0.019568
Uhrf1 Ubiquitin-like with PHD and ring finger domains 1 1.420107 0.043072
Usp18 Ubiquitin specific peptidase 18 0.238489 0.029154
Yeats4 YEATS domain containing 4 0.503128 0.019128
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